Meningitis management

Meningitis management


Marketed By :  FastBook Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 4,023

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. A ray of hope for the victims of meningitis – a new vaccine has been approved for treating meningitis B. The new vaccine, which medical researchers have named as 4CMenB vaccine, has been developed and manufactured by the pharmaceutical company Novartis. It is essential to note that the 4CMenB vaccine is the first meningitis B vaccine which has been approved for use in the United Kingdom. Besides, the vaccine has received a positive verdict from the European Medicines Agency which indicates that the 4CMenB vaccine is safe and effective. Nonetheless, Novartis has said the immunization has had side effects such as fever and redness at the injection site. Also known as Bexsero, the vaccine 4CMenB is medically recommended for use in children aged two months and older. Did you know that there is an average of 1 870 people who suffers from meningitis B in Great Britain. Official medical reports have also revealed that among the victims, 85% are children. Meningitis B also referred to as the meningococcal disease is caused by Neisseria meningitidis group B...

Product Specifications
SKU :COC29735
Country of ManufactureIndia
Product BrandFastBook Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-29
0 Review(s)